Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

880
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
880
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothers.

iScience·2026
Same author

A scalable, low-cost, sample hashing workflow for multiomic single-cell analysis using the Seq-Well S<sup>3</sup> platform.

Nature protocols·2026
Same author

Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials.

The lancet. HIV·2026
Same author

Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114.

Science translational medicine·2026
Same author

Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection.

NPJ vaccines·2026
Same author

Minor SHIV variants abrogate protective efficacy of broadly neutralizing antibodies in rhesus macaques.

Nature communications·2025
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
Same journal

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026
Same journal

The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026
Same journal

Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection.

Immunity·2026
Same journal

Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes.

Immunity·2026
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.2K

HIV-1 Latency by Transition.

Boris Julg1, Dan H Barouch1

  • 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA.

Immunity
|October 19, 2017
PubMed
Summary
This summary is machine-generated.

The latent HIV-1 reservoir is a major hurdle for curing HIV. Shan et al. found that effector-to-memory transitioning CD4+ T cells are highly susceptible to establishing latent HIV-1 infection.

More Related Videos

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.4K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

10.7K

Related Experiment Videos

Last Updated: Feb 20, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.2K
Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.4K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

10.7K

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • The latent HIV-1 reservoir is the primary obstacle to achieving a cure for HIV-1.
  • Understanding the cellular targets of HIV-1 infection is crucial for developing eradication strategies.

Purpose of the Study:

  • To identify specific CD4+ T cell subsets that are particularly permissive for establishing latent HIV-1 infection.
  • To investigate the role of effector-to-memory transitioning (EMT) CD4+ T cells in HIV-1 latency.

Main Methods:

  • Analysis of CD4+ T cell populations.
  • Assessment of HIV-1 permissiveness in different T cell subsets.
  • Characterization of effector-to-memory transitioning (EMT) CD4+ T cells.

Main Results:

  • Effector-to-memory transitioning (EMT) CD4+ T cells were found to be highly permissive for the establishment of latent HIV-1 infection.
  • These findings highlight a specific cellular target for persistent HIV-1 reservoirs.

Conclusions:

  • Effector-to-memory transitioning (EMT) CD4+ T cells are a key cellular reservoir for latent HIV-1.
  • Targeting these cells may be a critical strategy for HIV-1 cure research.